Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Transgene (Production Asset)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Production unit in Strasbourg, France. The unit is designed and equipped to manufacture clinical lots of pharmaceuticals and vaccines using viral vectors.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
ABL (US)
Primary Office
  • Strasbourg
  • France

Transgene (Production Asset) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Transgene (Production Asset)‘s full profile, request access.

Request full access to PitchBook

Transgene (Production Asset) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Transgene (Production Asset)‘s full profile, request access.

Request full access to PitchBook